Key Takeaways A less expensive, generic version of the GLP-1 medication Victoza is coming to market Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no generic version of Ozempic THURSDAY, Dec
This is particularly valuable for athletes and active individuals who require adequate caloric intake to support training demands, for those following specific dietary protocols that rely on intact hunger cues, or for anyone seeking body composition improvements without the complications of appetite manipulation
10 Reduced glutathione is associated with higher oxidative stress, 11 which contributes to damage 12 in the trabecular meshwork cells and retinal ganglion cells, worsening glaucoma and accelerating optic nerve damage
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for obesity treatment, and whilst it affects glucose metabolism, its risk of causing hypoglycaemia varies significantly depending on whether you have diabetes and what other medications you take
RETA again led to significantly delayed tumor onset and blunted tumor growth over the course of the study (Fig
/assets/images/provider/photos/2775905.jpeg)
